# Fanni Rencz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fanni-rencz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,577 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 34 |
| i10-index | 95 |
| Last Known Institution | Semmelweis University |
| OpenAlex ID | https://openalex.org/A5024021740 |
| ORCID iD | 0000-0001-9674-620X |
| Works | 245 |

## Researcher papers

- [Alopecia areata and health-related quality of life: a systematic review and meta-analysis](https://scholariq.org/papers/alopecia-areata-and-health-related-quality-of-life-a-systematic-review-and-meta/)
- [EQ-5D in Central and Eastern Europe: 2000–2015](https://scholariq.org/papers/eq-5d-in-central-and-eastern-europe-2000-2015/)
- [Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary](https://scholariq.org/papers/parallel-valuation-of-the-eq-5d-3l-and-eq-5d-5l-by-time-trade-off-in-hungary/)
- [Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary](https://scholariq.org/papers/exploring-the-relationship-between-eq-5d-dlqi-and-pasi-and-mapping-eq-5d/)
- [Psychometric properties of the Hungarian version of the eHealth Literacy Scale](https://scholariq.org/papers/psychometric-properties-of-the-hungarian-version-of-the-ehealth-literacy-scale/)
- [Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria](https://scholariq.org/papers/health-technology-assessment-in-poland-the-czech-republic-hungary-romania-and/)
- [The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries](https://scholariq.org/papers/the-rituximab-biosimilar-ct-p10-in-rheumatology-and-cancer-a-budget-impact/)
- [Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients](https://scholariq.org/papers/measurement-properties-of-the-eq-5d-5l-compared-to-the-eq-5d-3l-in-psoriasis/)
- [Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/comprehensive-score-for-financial-toxicity-and-health-related-quality-of-life-in/)
- [A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia](https://scholariq.org/papers/a-budget-impact-model-for-biosimilar-infliximab-in-crohn-s-disease-in-bulgaria/)
- [Societal costs and health related quality of life in adult atopic dermatitis](https://scholariq.org/papers/societal-costs-and-health-related-quality-of-life-in-adult-atopic-dermatitis/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Researcher university

- [Semmelweis University](https://scholariq.org/institutions/semmelweis-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.